Skip to main content
NanoVibronix, Inc. logo

NanoVibronix, Inc. — Investor Relations & Filings

Ticker · NAOV ISIN · US63008J7028 LEI · 5493008114LTFZQ2I595 US Manufacturing
Open in API
Filings indexed 512 across all filing types
Latest filing 2022-09-14 Regulatory Filings
Country US United States of America
Listing US NAOV

About NanoVibronix, Inc.

https://nanovibronix.com/

NanoVibronix, Inc. is a medical technology company that develops non-invasive and minimally invasive biological response-activating devices. The company's core technology is based on a proprietary, patented low-intensity surface acoustic wave (SAW) ultrasound. Its main products include PainShield®, a portable device for pain therapy and the treatment of nerve and soft tissue damage, and UroShield®, an ultrasound device designed to prevent bacterial biofilm on urinary catheters. These prescription-based products offer therapeutic alternatives to medication for pain management, wound healing, and biofilm prevention, targeting both clinical and home care settings.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. The text describes the registration of Series F Preferred Stock, including details about voting rights, dividend rights, redemption, and other characteristics. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. The document is not an announcement of a report but the actual registration statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-09-14 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The content specifically states that the company is postponing its Annual Meeting of Shareholders and will announce the new date and record date later. This is an announcement related to the Annual General Meeting (AGM) but does not contain the AGM materials or presentations themselves. The document is short (3235 characters) and serves as a notification of a change in the AGM schedule, not the AGM report or materials. Therefore, it fits best under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories like AGM Information or Proxy Solicitation. The document is not a full report, financial statement, or voting result announcement, nor is it a management or audit report. Hence, the classification is RNS with high confidence.
2022-09-02 English
Delisting Announcement 2022
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content specifically discusses a notice of delisting from Nasdaq due to non-compliance with minimum bid price requirements, including details about the company's response and a press release attachment. There are no financial statements or detailed financial data presented, and the document is relatively short (4571 characters). This matches the definition of a Delisting Announcement (DLST), which is an official notice that the company's stock will be removed from an exchange. Therefore, the correct classification is DLST with high confidence.
2022-09-02 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Q2 2022
2022-08-16 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement Classification · 100% confidence The document is identified as a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is labeled as a Definitive Additional Materials filing related to a proxy statement. Proxy statements are materials sent to shareholders to provide information and request votes for meetings. The document length is short (2085 characters) and does not contain financial statements or detailed financial data, but rather appears to be supplementary proxy materials. Therefore, the appropriate classification is Proxy Solicitation & Information Statement (PSI).
2022-07-26 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement
2022-07-26 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.